A self-improving AI system now rewrites its own code, tests itself, and evolves — a leap that challenges how we build and ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company ...

Pyrefly is not the first Python type-checking tool from Meta. Previously, the company delivered Pyre, written in OCaml. Pyre ...

How Instagram's 'yoink guy' uses Florida wildlife to captivate almost 8 million people and what to know about the 2025 Python ...

Summary I now rate Recursion Pharma a sell due to disappointing recent trial updates and uncertain future prospects. REC-4881's phase 2 TUPELO trial showed mixed results, with one patient ...

Lloyd and Justin McClain, known as "Maryland Snake Man," helped contain, measure and report the 13-foot-long Burmese python on Monday. Lloyd was able to get the non-native python into a small gray ...

Boltz-2 was trained on a variety of data sources, including internal data from Recursion. The firm, which also provided computational support, had been using Boltz-1.

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitorsREC-4539, a ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...